Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Petmed Express Inc (PETS)

Petmed Express Inc (PETS)
3.13 -0.03 (-0.95%) 13:35 ET [NASDAQ]
3.12 x 100 3.14 x 5
Realtime by (Cboe BZX)
3.12 x 100 3.14 x 5
Realtime - - (-) -
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
3.13
Day High
3.27
Open 3.20
Previous Close 3.16 3.16
Volume 143,051 143,051
Avg Vol 198,765 198,765
Stochastic %K 15.34% 15.34%
Weighted Alpha -39.06 -39.06
5-Day Change +0.17 (+5.79%) +0.17 (+5.79%)
52-Week Range 2.90 - 6.85 2.90 - 6.85
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,273
  • Shares Outstanding, K 20,656
  • Annual Sales, $ 281,060 K
  • Annual Income, $ -7,460 K
  • EBIT $ 9 M
  • EBITDA $ 16 M
  • 60-Month Beta 0.99
  • Price/Sales 0.27
  • Price/Cash Flow 135.58
  • Price/Book 0.66

Options Overview Details

View History
  • Implied Volatility 95.50% ( +8.89%)
  • Historical Volatility 52.03%
  • IV Percentile 37%
  • IV Rank 13.22%
  • IV High 283.61% on 08/08/24
  • IV Low 66.83% on 12/24/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 138
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 6,369
  • Open Int (30-Day) 6,414

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +76.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.97 +7.58%
on 04/10/25
Period Open: 4.25
4.28 -25.35%
on 03/31/25
-1.06 (-24.82%)
since 03/21/25
3-Month
2.97 +7.58%
on 04/10/25
Period Open: 5.00
5.58 -42.74%
on 02/05/25
-1.81 (-36.10%)
since 01/22/25
52-Week
2.90 +10.17%
on 08/13/24
Period Open: 4.05
6.85 -53.36%
on 12/09/24
-0.86 (-21.11%)
since 04/22/24

Most Recent Stories

More News
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th

PETS : 3.13 (-0.95%)
PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors

PETS : 3.13 (-0.95%)
Bear of the Day: PetMed Express (PETS)

PetMed Express (PETS) is built around an appealing concept—capitalizing on the rapidly growing pet ownership trend by offering pet medications and health products through an online platform. In theory,...

PETS : 3.13 (-0.95%)
PetMed: Fiscal Q3 Earnings Snapshot

PetMed: Fiscal Q3 Earnings Snapshot

PETS : 3.13 (-0.95%)
PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

PETS : 3.13 (-0.95%)
PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

PETS : 3.13 (-0.95%)
PetMed Express, Inc. to Participate in the 27th Annual ICR Conference

PETS : 3.13 (-0.95%)
Insider Purchase: Director at $PETS (PETS) Buys 5,000 Shares

Leslie C.G. Campbell, a director at $PETS ($PETS), bought 5,000 shares of the company on 12-04-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their...

PETS : 3.13 (-0.95%)
PetMed Express, Inc. Adopts Shareholder Rights Plan to Safeguard Investments

PetMed Express adopts a shareholder rights plan to protect against unwanted stock accumulations, ensuring long-term shareholder value.Quiver AI SummaryPetMed Express, Inc. has announced the adoption of...

PETS : 3.13 (-0.95%)
PetMeds® Adopts Limited Duration Shareholder Rights Plan

PETS : 3.13 (-0.95%)
Why Madrigal Pharmaceuticals Stock Is Sinking Today

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came after the drugmaker announced its preliminary fourth-quarter and full-year 2024...

MDGL : 297.18 (+0.73%)
Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra

MDGL : 297.18 (+0.73%)
Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MDGL : 297.18 (+0.73%)
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon

Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.

NVO : 59.38 (+1.80%)
MDGL : 297.18 (+0.73%)
LLY : 820.34 (+0.28%)
Insider Sale: Director at $MDGL (MDGL) Sells 520 Shares

FRED B CRAVES, a director at $MDGL ($MDGL), sold 520 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.5% of their shares....

MDGL : 297.18 (+0.73%)
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

Ken Griffin started the Citadel hedge fund in 1990. It's become so successful that his net worth has risen to a stunning $46 billion.

VKTX : 24.89 (+4.93%)
RILY : 3.08 (+4.41%)
NVO : 59.38 (+1.80%)
MDGL : 297.18 (+0.73%)
LLY : 820.34 (+0.28%)
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move

When a company's shares shoot up 82% in 12 months, investors clearly think it's a good time to be a shareholder -- and that's exactly what's happened to the stock of Madrigal Pharmaceuticals (NASDAQ: MDGL)...

MDGL : 297.18 (+0.73%)
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics...

CORT : 62.40 (-0.79%)
TBPH : 9.25 (+1.31%)
MDGL : 297.18 (+0.73%)
LRMR : 2.24 (+11.44%)
CPRX : 22.58 (+2.54%)
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More

There's a bright future ahead for this company.

MDGL : 297.18 (+0.73%)
5 Small Drug Stocks to Buy as Trump Gets Re-Elected

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the biotech...

CORT : 62.40 (-0.79%)
TBPH : 9.25 (+1.31%)
MDGL : 297.18 (+0.73%)
LRMR : 2.24 (+11.44%)
CPRX : 22.58 (+2.54%)
Why Madrigal Pharmaceuticals Stock Is Sinking Today

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came after the drugmaker announced its preliminary fourth-quarter and full-year 2024...

MDGL : 297.18 (+0.73%)
Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra

MDGL : 297.18 (+0.73%)
Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MDGL : 297.18 (+0.73%)
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon

Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.

NVO : 59.38 (+1.80%)
MDGL : 297.18 (+0.73%)
LLY : 820.34 (+0.28%)
Insider Sale: Director at $MDGL (MDGL) Sells 520 Shares

FRED B CRAVES, a director at $MDGL ($MDGL), sold 520 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.5% of their shares....

MDGL : 297.18 (+0.73%)
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

Ken Griffin started the Citadel hedge fund in 1990. It's become so successful that his net worth has risen to a stunning $46 billion.

VKTX : 24.89 (+4.93%)
RILY : 3.08 (+4.41%)
NVO : 59.38 (+1.80%)
MDGL : 297.18 (+0.73%)
LLY : 820.34 (+0.28%)
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move

When a company's shares shoot up 82% in 12 months, investors clearly think it's a good time to be a shareholder -- and that's exactly what's happened to the stock of Madrigal Pharmaceuticals (NASDAQ: MDGL)...

MDGL : 297.18 (+0.73%)
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics...

CORT : 62.40 (-0.79%)
TBPH : 9.25 (+1.31%)
MDGL : 297.18 (+0.73%)
LRMR : 2.24 (+11.44%)
CPRX : 22.58 (+2.54%)
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More

There's a bright future ahead for this company.

MDGL : 297.18 (+0.73%)
5 Small Drug Stocks to Buy as Trump Gets Re-Elected

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the biotech...

CORT : 62.40 (-0.79%)
TBPH : 9.25 (+1.31%)
MDGL : 297.18 (+0.73%)
LRMR : 2.24 (+11.44%)
CPRX : 22.58 (+2.54%)

Business Summary

PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive...

See More

Key Turning Points

3rd Resistance Point 3.40
2nd Resistance Point 3.33
1st Resistance Point 3.24
Last Price 3.13
1st Support Level 3.08
2nd Support Level 3.01
3rd Support Level 2.92

See More

52-Week High 6.85
Fibonacci 61.8% 5.34
Fibonacci 50% 4.88
Fibonacci 38.2% 4.41
Last Price 3.13
52-Week Low 2.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.